JP2007531741A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531741A5
JP2007531741A5 JP2007506363A JP2007506363A JP2007531741A5 JP 2007531741 A5 JP2007531741 A5 JP 2007531741A5 JP 2007506363 A JP2007506363 A JP 2007506363A JP 2007506363 A JP2007506363 A JP 2007506363A JP 2007531741 A5 JP2007531741 A5 JP 2007531741A5
Authority
JP
Japan
Prior art keywords
virus
hepatitis
polypeptide
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506363A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007531741A (ja
JP4896005B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/011450 external-priority patent/WO2005097165A2/en
Publication of JP2007531741A publication Critical patent/JP2007531741A/ja
Publication of JP2007531741A5 publication Critical patent/JP2007531741A5/ja
Application granted granted Critical
Publication of JP4896005B2 publication Critical patent/JP4896005B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007506363A 2004-04-02 2005-04-04 Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 Expired - Lifetime JP4896005B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US55908104P 2004-04-02 2004-04-02
US60/559,081 2004-04-02
US60923804P 2004-09-13 2004-09-13
US60/609,238 2004-09-13
US63414404P 2004-12-08 2004-12-08
US60/634,144 2004-12-08
PCT/US2005/011450 WO2005097165A2 (en) 2004-04-02 2005-04-04 Il-28 and il-29 cysteine mutants for treating viral infection

Publications (3)

Publication Number Publication Date
JP2007531741A JP2007531741A (ja) 2007-11-08
JP2007531741A5 true JP2007531741A5 (https=) 2008-03-06
JP4896005B2 JP4896005B2 (ja) 2012-03-14

Family

ID=34965116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506363A Expired - Lifetime JP4896005B2 (ja) 2004-04-02 2005-04-04 Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法

Country Status (7)

Country Link
US (7) US20050244423A1 (https=)
EP (1) EP1750749A2 (https=)
JP (1) JP4896005B2 (https=)
AU (1) AU2005231476B2 (https=)
CA (1) CA2558829C (https=)
IL (1) IL177640A0 (https=)
WO (1) WO2005097165A2 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927040B2 (en) * 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
US7910313B2 (en) 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
EP1575609A4 (en) * 2002-10-23 2010-12-15 Zymogenetics L L C METHOD FOR THE TREATMENT OF VIRUS INFECTIONS USING IL-28 AND IL-29
EP1927600A1 (en) 2003-08-07 2008-06-04 Zymogenetics, Inc. Homogeneous preparations of IL-28 and IL-29
GB0405634D0 (en) 2004-03-12 2004-04-21 Univ Southampton Anti-virus therapy for respiratory diseases
WO2005097165A2 (en) 2004-04-02 2005-10-20 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
JP2009502803A (ja) * 2005-07-20 2009-01-29 ザイモジェネティクス， インコーポレイテッド Ｉｌ−２８およびｉｌ−２９のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
WO2007041713A1 (en) * 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
WO2009009115A2 (en) * 2007-07-11 2009-01-15 Nevsky Pharmaceutical Development Liposome compositions for treatment of hepatitis c
US10071154B2 (en) * 2008-04-04 2018-09-11 The Trustees Of The University Of Pennsylvania Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
JP2011522834A (ja) * 2008-06-05 2011-08-04 ザイモジェネティクス リミテッド ライアビリティ カンパニー Ｃ型肝炎の治療のためのペグ化ｉｉｉ型インターフェロンの使用
WO2010045261A1 (en) * 2008-10-13 2010-04-22 Zymogenetics, Llc Single chain fc type iii interferons and methods of using same
US20100316608A1 (en) * 2009-06-15 2010-12-16 Vijayaprakash Suppiah Method of Determining A Response To Treatment With Immunomodulatory Composition
CN102559737A (zh) * 2011-12-13 2012-07-11 江南大学 一种人白细胞介素29的变异体及其制备方法
AU2013323472B2 (en) * 2012-09-28 2018-07-05 Ellis KLINE Glycosidase regimen for treatment of infectious disease
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
WO2016172342A1 (en) 2015-04-21 2016-10-27 Eiger Biopharmaceuticals, Inc. Pharmaceutical compositions comprising lonafarnib and ritonavir
JP7674628B2 (ja) 2016-02-19 2025-05-12 イーアイティー・ファーマ・インコーポレイテッド インターフェロンラムダによるデルタ型肝炎ウイルス感染の処置
CN114901822A (zh) 2019-12-23 2022-08-12 维萨梅布有限公司 用于同时调节基因表达的组合物和方法
US20230201308A1 (en) * 2020-02-06 2023-06-29 Eiger Biopharmaceuticals, Inc. Treatment of coronavirus infection with interferon lambda
WO2021159027A1 (en) * 2020-02-06 2021-08-12 Eiger Biopharmaceuticals, Inc. Treatment of coronavirus infection with interferon lambda
CN117024530B (zh) * 2023-07-20 2024-03-19 中国人民解放军空军军医大学 抗微生物肽Perceptide-TJ-2及其在制备广谱抗病毒药物中的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54096B1 (en) 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
WO2001081359A1 (en) * 2000-04-20 2001-11-01 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
US6927040B2 (en) 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
JP2004509617A (ja) 2000-09-08 2004-04-02 シェーリング　コーポレイション 哺乳動物遺伝子；関連試薬および方法
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
EP1942187B1 (en) * 2001-04-20 2010-09-22 ZymoGenetics, L.L.C. Cytokine protein family
WO2002092762A2 (en) 2001-05-10 2002-11-21 Immunex Corporation Cytokine polypeptides
WO2003066002A2 (en) 2002-02-08 2003-08-14 University Of Medicine And Dentistry Of New Jersey IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
EP2295455A1 (en) 2002-04-19 2011-03-16 ZymoGenetics, L.L.C. Cytokine receptor
EP1575609A4 (en) * 2002-10-23 2010-12-15 Zymogenetics L L C METHOD FOR THE TREATMENT OF VIRUS INFECTIONS USING IL-28 AND IL-29
EP1927600A1 (en) * 2003-08-07 2008-06-04 Zymogenetics, Inc. Homogeneous preparations of IL-28 and IL-29
WO2005097165A2 (en) * 2004-04-02 2005-10-20 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
JP2009502803A (ja) 2005-07-20 2009-01-29 ザイモジェネティクス， インコーポレイテッド Ｉｌ−２８およびｉｌ−２９のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法
JP2011522834A (ja) 2008-06-05 2011-08-04 ザイモジェネティクス リミテッド ライアビリティ カンパニー Ｃ型肝炎の治療のためのペグ化ｉｉｉ型インターフェロンの使用

Similar Documents

Publication Publication Date Title
JP2007531741A5 (https=)
ES2207830T3 (es) Conjugados de polietilenglicol-interferon alfa para la terapia de infecciones.
AR021876A1 (es) Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado
JP2010503396A5 (https=)
ATE377422T1 (de) Nucleosid-analoga mit monozyklischen basischen carboxamidingruppen
EP2440251A1 (en) Administration of interferon for prophylaxis against or treatment of pathogenic infection
JP2008518943A5 (https=)
JP2003535043A5 (https=)
JP2006506097A5 (https=)
JP2005525784A5 (https=)
Alexenko et al. The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential
JP2023510864A (ja) グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の持続型結合体の肺疾患の治療的使用
JP2008503207A5 (https=)
KR20070090002A (ko) 인터페론―베타로 아시아 인구 집단의 ｃ형 간염 치료
JP5209462B2 (ja) コンセンサスインターフェロンの使用方法
Dahl et al. In vitro inhibition of SARS virus replication by human interferons
EP1797112B1 (en) Inhibitors of hepatitits c virus
CA2430115A1 (en) Recombinant rsv virus expression systems and vaccines
JP2009504135A5 (https=)
JP2009529048A (ja) 経口インターフェロンによる広域免疫および抗ウイルス遺伝子調節
JP2009232836A5 (https=)
JP2007516214A5 (https=)
AU729514B2 (en) Stimulation of host defense mechanisms against viral challenges
Schellekens et al. Oromucosal interferon therapy: relationship between antiviral activity and viral load
Reichard et al. Ribavirin: A possible alternative for the treatment of chronic non-A, non-B hepatitis